Postponement of ruling on key pharma “pipeline patents” case leaves Brazilian life sciences industry in lurch

Postponement of ruling on key pharma “pipeline patents” case leaves Brazilian life sciences industry in lurch

Supreme Court has taken nearly a decade to rule on a constitutional challenge to a controversial law allowing pharma companies to bypass the regular patenting process

Unlock unlimited access to all IAM content